Cetirizine Hydrochloride

CAS 83881-52-1 23 current records 5 historicalSmall Molecule

Who holds supplier records for Cetirizine Hydrochloride? 23 organisations hold a current record for Cetirizine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (17), Israel (2), Italy (1), China (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cetirizine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cetirizine-hydrochloride

Reading the evidence

  • 23 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    17 of the 22 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 16 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (23)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cetirizine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India17Israel2Italy1China1Germany1Country not recorded for 1
Need Cetirizine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (14)

Certificates of Suitability on the EDQM register for Cetirizine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 20 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
INDOCO REMEDIES LIMITED MumbaiIN
CEP 2021-475 - Rev 02
Cetirizine dihydrochloride
Sept 2026—
SUPRIYA LIFESCIENCE LIMITED MumbaiIN
CEP 2024-076 - Rev 00
Cetirizine dihydrochloride
Jun 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2000-031 - Rev 14
Cetirizine dihydrochloride
May 2026—
CIPLA LIMITED MumbaiIN
CEP 2000-081 - Rev 08
Cetirizine dihydrochloride
Oct 2025—
WAVELENGTH ENTERPRISES LTD. Petah TikvaIL
CEP 2021-309 - Rev 03
Cetirizine dihydrochloride, Process B
Sept 2025—
GRANULES INDIA LIMITED HyderabadIN
CEP 2009-349 - Rev 03
Cetirizine dihydrochloride
Aug 2025—
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2006-309 - Rev 02
Cetirizine dihydrochloride
Aug 2025—
THINQ PHARMA-CRO LIMITED ThaneIN
CEP 2016-066 - Rev 01
Cetirizine dihydrochloride
Aug 2024—
PRAVEEN LABORATORIES PRIVATE LIMITED SuratIN
CEP 2021-438 - Rev 00
Cetirizine dihydrochloride
May 2024—
AREVIPHARMA GMBH RadebeulDE
R1-CEP 2006-220 - Rev 04
Cetirizine dihydrochloride
Sept 2022—
JUBILANT PHARMOVA LIMITED NanjangudIN
R1-CEP 2007-114 - Rev 05
Cetirizine dihydrochloride
Aug 2022—
GLOCHEM INDUSTRIES PRIVATE LIMITED HyderabadIN
R1-CEP 2003-171 - Rev 06
Cetirizine dihydrochloride
Jan 2022—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2009-206 - Rev 03
Cetirizine dihydrochloride, Process II
Jan 2020—
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
R1-CEP 2001-144 - Rev 06
Cetirizine dihydrochloride
Aug 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Cetirizine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 5 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Cetirizine Hydrochloride is a second-generation antihistamine used in the treatment of allergic rhinitis and chronic urticaria. It acts by selectively inhibiting the peripheral H1 receptors without significant sedation.

Chemical identity

IUPAC name
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
Canonical SMILES
C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl
InChIKey
PGLIUCLTXOYQMV-UHFFFAOYSA-N
Synonyms
Zyrtec API, cetirizine dihydrochloride, cetirizine hcl, cetrine, nsc-759102, p-071, p071, quzyttir, zerviate, zyrtec

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Histamine-1 Receptor Antagonist
Mechanism of action
Histamine H1 Receptor Antagonists

Therapeutic areas

AllergyImmunology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cetirizine Hydrochloride?

23 organisations hold an active US FDA Type II Drug Master File or a CEP for Cetirizine Hydrochloride: WAVELENGTH ENTERPRISES LTD (Israel), Cipla Limited (India), Dr. Reddy's Laboratories Ltd. (India), GLOCHEM INDUSTRIES LTD (India), Granules India Limited (India), Ipca Laboratories Limited (India), MATRIX PHARMACORP PRIVATE LTD (India) and PRAVEEN LABORATORIES PVT LTD (India), and 15 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cetirizine Hydrochloride Drug Master Files are active?

WAVELENGTH ENTERPRISES LTD (DMF 16244, 35022), Cipla Limited (DMF 15145), Dr. Reddy's Laboratories Ltd. (DMF 18395), GLOCHEM INDUSTRIES LTD (DMF 26467, 19273), Granules India Limited (DMF 30063), Ipca Laboratories Limited (DMF 26033, 20997), MATRIX PHARMACORP PRIVATE LTD (DMF 17741) and PRAVEEN LABORATORIES PVT LTD (DMF 43517) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cetirizine Hydrochloride records mean?

5 organisations have only inactive Type II DMFs for Cetirizine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Cetirizine Hydrochloride have a European Certificate of Suitability?

Yes. 14 organisations hold a valid CEP for Cetirizine Hydrochloride on the EDQM register, including INDOCO REMEDIES LIMITED Mumbai (IN), SUPRIYA LIFESCIENCE LIMITED Mumbai (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), CIPLA LIMITED Mumbai (IN), WAVELENGTH ENTERPRISES LTD. Petah Tikva (IL) and GRANULES INDIA LIMITED Hyderabad (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Cetirizine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cetirizine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.